Abstract
Canine oral malignant melanomas (OMMs) exhibit a variety of morphologic phenotypes, including a spindloid variant. The microscopic diagnosis of spindloid OMMs is based on junctional activity and/or the presence of melanin pigment. In the absence of these features, spindloid OMMs are difficult to differentiate from soft tissue sarcomas (STS). An antibody cocktail (MDX) that includes Melan-A, PNL2, and tyrosinase-related proteins 1 and 2 (TRP-1 and TRP-2) is the current gold standard for identifying amelanotic OMMs by immunohistochemistry (IHC). However, MDX is less sensitive for diagnosing spindloid amelanotic OMMs. This raises concern for biopsy specimens that lack overlying epithelium, making it potentially difficult to differentiate OMM from STS by IHC. The goal of this study was to identify additional markers to help differentiate between STS and OMMs that lack pigment and junctional activity. SOX-10 has recently been proposed as a sensitive marker for melanocytes in humans but has not been validated in dogs. Similarly, RNA expression for various genes has been analyzed in humans, but not in the context of diagnosing canine melanocytic neoplasms. For this retrospective study, formalin-fixed, paraffin-embedded tissues from 20 OMMs, 20 STS, and 20 oral spindle cell tumors (OSCTs) that lacked junctional activity and pigmentation were selected. IHC for MDX, SOX-10, and laminin, in parallel with RT-qPCR of TYR, SOX10, CALD1, CD34, DES, and LAMA1, was performed in all cases. TYR, CD34, and CALD1 were the most discriminatory genes in differentiating between OMM and STS, all having 100% specificity and 65, 95, and 60% sensitivity, respectively. While all 20 OMMs were immunohistochemically labeled for SOX-10, two STS were also labeled (100% sensitivity and 90% specificity). MDX IHC labeled all 20 OMMs and no STS. Surprisingly, none of the 20 OSCTs expressed TYR RNA above the cutoff, and 14/20 OSCTs expressed CALD1 or CD34 RNA above the cutoff, thereby confirming them as STS. Four OSCT were suspect STS, and no OSCTs were confirmed as OMMs based on IHC and RNA expression patterns. In conclusion, the RNA levels of TYR, CD34, and CALD1 should be evaluated in suspected amelanotic OMMs that are negative for MDX to accurately differentiate between OMM and STS.
Highlights
Oral malignant melanomas (OMMs) are the most common malignant oral neoplasm in dogs [1,2,3]
SOX-10 IHC labeling was seen in all 20 OMMs, but two soft tissue sarcomas (STS) labeled as well (100% sensitivity and 90% specificity in diagnosing OMM)
Six of the oral spindle cell tumors (OSCTs) labeled for SOX-10 (Figure 5; Table 2)
Summary
Oral malignant melanomas (OMMs) are the most common malignant oral neoplasm in dogs [1,2,3]. In the absence of these morphologic features, spindloid amelanotic OMMs are difficult to differentiate from oral soft tissue sarcomas (STS) microscopically [8] Such distinction is important as STS, in contrast to OMMs, rarely metastasize and are primarily treated with surgery and/or radiation therapy with a significantly longer reported median survival time of 540 days [8]. While some antibodies such as Melan-A and PNL2 have been shown to be highly specific in differentiating OMMs from STS, other antibodies with high sensitivity for detecting OMMs, such as MITF-1 and S100, have poor specificity and label a large percentage of STS [3]. The true incidence of OMMs within this specific group of oral spindle cell tumors (OSCTs) that lack pigmentation and junctional activity is unknown, and identification of novel markers capable of differentiating between OMMs and STS would advance our diagnostic capabilities
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
